Searched for
KRSNAA DIAGNOSTICS LISTING
How would Krsnaa Diagnostics' focus on radiology testing impact its margin, profit?When Krsnaa Diagnostics came up with its IPO last year, it introduced a unique business model in the listed diagnostics space. In the diagn...
Ami Organics commands 25% grey market premium; Vijaya's tepid at 1%The two issues, which opened on September 1 and closed on September 3, will likely see the finalisation of share allotment on Wednesday. Th...
IPO listing scorecard in August: 5 winners and 5 losersEuphoric performance of IPOs during 2020 and in the first eight months of this year also had its fallout. Oversupply, fall in quality, and ...
Should you still invest in Vijaya IPO despite Krsnaa's poor show?At the upper end of the price band, the IPO is valued at 64 times FY21 earnings, which is at a 15-40 per cent discount to bigger peers Metr...
Bet on Vijaya Diagnostics after a hard look at industry prospectsUnorganised smaller players are giving way to larger organised chains. VDL is an emerging integrated player but comes with a high regional ...
Vijaya Diagnostic Centre IPO: Grey market signals little upsideMarketmen tracking grey market moves said activity may pick up pace early next week. The Rs 1,894 crore Vijaya Diagnostic Centre IPO would ...
Vijaya Diagnostic Centre IPO: Dates, price band and other details you need to know before applyingHere are key things you should know about the Rs 1,894-crore IPO of Vijaya Diagnostic Centre.
Devyani lists at 56% premium to IPO price, others witness muted debutsShares of Devyani International listed at a premium of more than 56% to their offer price while the other three companies that debuted alon...
NSE-BSE bulk deals: Morgan Stanley sells stake in Exxaro TilesIn another transaction, Birla Sun Life Insurance Company bought 230,000 shares of newly-listed Krsnaa Diagnostics at Rs. 1,023.3 apiece thr...
3 out of 4 stocks make dull debut on Dalal Street: Is the IPO party over?Astha Jain of Hem Securities suggested that investors should book partial profits in Krsnaa Diagnostics and Exxaro Tiles.
Krsnaa Diagnostics lists at 7% premium over issue priceThe IPO was subscribed on the first day itself. Overall, the issue received bids for 45,80,08,245 shares, which was 64.40 times the issue s...
IPO grey market getting its mojo back after BSE clarificationPremia of these listing candidates in the unofficial market were hammered badly after sentiment in the second rung stocks took a hit, subsc...
Krsnaa Diagnostics GMP at 38%; here's how to check allotmentKrsnaa Diagnostics shares are likely to get listed by August 17, Tuesday.
Krsnaa Diagnostics IPO subscribed 98.2 times on Day 3Religare Securities said that Krsnaa is well placed to benefit from growing industry trends on the back of its scale, strong brand equity, ...
Diagnostic chains eye IPO route to raise fundsThe euphoria is aided by a massive spike in the share prices of already listed entities such as Metropolis Healthcare, Dr Lal Pathlabs, Med...
IPO Street’s paved with gold? Retail investors can’t stop buyingThe average listing day gains of five IPOs in July was 76%. Tatva Chintan Pharma listed at a premium of 113%, GR Infraprojects rallied 109%...
4 IPOs going to leave you spoilt for choice: Should you go all in?They include Krsnaa Diagnostics, Devyani International, Exxaro Tiles and Windlas Biotech, which are going to raise close to Rs 3,614 crore ...
4 IPOs to keep market buzzing this week; to raise Rs 3,600 croreAnalysts and traders expect the issues to sail through given the demand for fresh issues in the market. The grey market premium has also ju...
India Inc seeks Rs 20,000 crore more in IPO seasonCompanies usually time their IPO launches based on the market sentiment and investor appetite for these share sales. Bankers said if the mo...
Krsnaa Diagnostics files papers for Rs 1,200 crore IPOFor the financial year ended March 31, 2020, the company's total income came in at Rs 271.38 crore as against Rs 214.31 crore for the previ...